# Community Health Systems account plan

> Community Health Systems is a US for-profit hospital operator with 60 hospitals in 12 states and $12,485 million of FY2025 net operating revenues.

## At a glance

Community Health Systems (NYSE: CYH), headquartered in Franklin, Tennessee, owns or leases acute care hospitals and runs physician practices, urgent care centers, freestanding emergency departments, imaging centers and ambulatory surgery centers, mostly in larger non-urban service areas. At September 30, 2026 it operated 60 affiliated hospitals with more than 8,000 beds and more than 800 sites of care in 32 markets across 12 states, down from 69 hospitals in 14 states at the end of 2025. FY2025 net operating revenues were $12,485 million (-1.2%), adjusted EBITDA $1,526 million (12.2% margin) and net income attributable to CHS $509 million. It employs approximately 57,000 people, including approximately 1,700 employed physicians. It reports a single segment, hospital operations.

## Business units

- **Indiana** (16.8% of 2025 net operating revenues): The largest state, with Lutheran Health Network in Fort Wayne (Lutheran Hospital, 396 beds) and Northwest Health in northwest Indiana (Porter Hospital, 287 beds; La Porte Hospital, 227). Indiana is a Medicaid expansion state, and CHS has committed up to $15 million toward a replacement facility in Starke County.
- **Alabama** (15.8% of 2025 net operating revenues): Hospitals include Grandview Medical Center in Birmingham (440 beds), Gadsden Regional Medical Center (346) and Flowers Hospital in Dothan (235). Crestwood Medical Center in Huntsville was sold to Huntsville Hospital Health System in 2026 under a $450 million agreement. Alabama did not expand Medicaid.
- **Texas** (11.9% of 2025 net operating revenues): Hospitals include Laredo Medical Center (326 beds), Longview Regional Medical Center (224) and DeTar Healthcare System in Victoria. Texas did not expand Medicaid and is in CMS's WISeR prior-authorization model from 2026.
- **Tennessee** (8.3% of 2025 net operating revenues): Tennova hospitals in the Knoxville area, including North Knoxville Medical Center (172 beds) and Turkey Creek Medical Center (111). The 80% interest in Tennova Healthcare - Clarksville was sold to Vanderbilt University Medical Center effective February 1, 2026 for approximately $623 million in cash.
- **Florida** (8.2% of 2025 net operating revenues): Physicians Regional Healthcare System in Naples, Lower Keys Medical Center in Key West, North Okaloosa Medical Center and Santa Rosa Medical Center. The share fell from 9.6% in 2024; Florida did not expand Medicaid and coastal facilities are exposed to hurricanes.
- **Other states** (about 39% of 2025 net operating revenues): Mississippi (Merit Health Central in Jackson, 379 beds), Arizona (Northwest Medical Center in Tucson, 242 beds), Missouri, New Mexico, Oklahoma, Georgia and Alaska. The Pennsylvania hospitals and four Arkansas hospitals were sold in 2026.

## Strategic priorities

- **Outpatient entry points**: The CEO names capital allocation into "high return outpatient entry points including ASCs, urgent care centers, free-standing EDs, and targeted physician practices"; in 2026 CHS took majority stakes in two ASCs and opened two de novo centers.
- **Portfolio pruning and debt reduction**: CHS says it may divest more hospitals outside its strategically beneficial service areas or with lower margins. 2026 divestitures covered about $1.6 billion of 2025 revenue for about $1.2 billion of net proceeds, and debt fell to about $9.6 billion at September 30, 2026.
- **Physician recruitment and retention**: Recruiting and employing primary care physicians and specialists, with standardized onboarding. Physician turnover is down over 40% and bedside RN turnover down 10%; the employed provider base grew 2.5%.
- **Cost control and centralization**: Finance, HR and supply chain run on a recently implemented ERP. Cost actions taken in 2026 should save about $100 million a year through department restructuring, purchased-services control and supply contracting.
- **Consumer experience and quality**: Central and online scheduling, a centralized transfer center, patient navigation, virtual care and patient portals; 12 hospitals earned a Leapfrog A grade and approximately 70% earned A or B grades.

## Latest results

In Q3 2026 net operating revenues were $2.757 billion vs $3.087 billion a year earlier, the fall coming from divested hospitals, while same-store revenues rose 3.8%. Adjusted EBITDA was $280 million at a 10.2% margin vs 12.2%, and the net loss attributable to CHS was $(86) million vs $130 million income. Almost half the adjusted-admission growth came from uninsured patients, and self-pay rose to 1.7% of revenue (0.8% a year earlier). Nine-month operating cash flow was $(55) million vs $277 million on higher patient receivables. 2026 guidance was cut again to net revenue of $11.3-11.5 billion, adjusted EBITDA of $1.225-1.275 billion and operating cash flow of $100-300 million, with capex unchanged at $350-400 million.

## Investments and deals

- **Hospital divestitures**: 2025: four hospitals divested and majority interests sold in three, with net proceeds over $1.0 billion. 2026: four Arkansas hospitals (sold for $110 million), three Pennsylvania hospitals, Crestwood Medical Center and the 80% Clarksville interest.
- **Lab outreach sale**: The ambulatory lab outreach business in 13 states was sold to Labcorp for about $194 million in 2025.
- **ASCs and physician practices**: About $54 million paid in 2026 for physician practices, clinics and controlling interests in two ambulatory surgery centers, including Surgical Institute of Alabama and South Anchorage Surgery Center.
- **Capital expenditure**: Capex was $335 million in 2025 and is guided at $350-400 million for 2026, about 50% of it for growth projects such as freestanding EDs, ASCs, higher-acuity service lines and IT.
- **Rural Health Transformation awards**: CHS accepted about $27 million of Rural Health Transformation Program Year 1 awards, mainly for capex and software, with spending funded through September 30, 2027.

## Challenges and risks

- **Uninsured and self-pay growth**: After enhanced ACA subsidies expired at the end of 2025, the exchange disenrollment impact is estimated at $80-90 million for 2026, and charity-care foregone revenue reached 21.2% of Q3 2026 revenue (13.6% a year earlier).
- **High leverage**: Net leverage rose to 7.2x despite $810 million of debt reduction year to date; interest expense was $870 million in 2025.
- **Deferred elective procedures**: Commercially insured patients facing higher copays and deductibles are putting off orthopedic and general surgery; management calls the care deferred rather than lost.
- **Medical specialist fees**: Fees for anesthesia and radiology rose 13% in Q3 2026 against an initial 5% to 8% assumption, and are expected to keep growing well above inflation in 2027.
- **Medicaid policy and slower payers**: The 2025 Reconciliation Law brings Medicaid work requirements and provider-tax limits; payers are auditing more claims before paying, growing receivables.

## What leadership says

> "care is being deferred rather than lost to competitors" — Kevin Hammons, Chief Executive Officer, Q3 2026 earnings call, 2026-10-29

> "substantially all of the growth in ER visits have come from uninsured patients" — Kevin Hammons, Chief Executive Officer, Q3 2026 earnings call, 2026-10-29

> "continued consumer insecurity related to geopolitical instability and inflationary pressures" — Kevin Hammons, Chief Executive Officer, Q2 2026 earnings call, 2026-07-23

> "We underestimated how much of an impact—how many people would continue to come to our health system." — Jason Johnson, EVP and CFO, Q2 2026 earnings call, 2026-07-23


## Where a supplier can help

- **Building outpatient sites**: The outpatient entry points priority and the capex plan (ASCs, urgent care, freestanding EDs) open room for suppliers of equipment, construction, imaging and clinic fit-out.
- **Revenue cycle and self-pay collections**: With uninsured volumes growing, payers auditing more claims and receivables rising, providers of eligibility screening, patient financing and collections tools address a stated challenge.
- **Purchased-services and supply savings**: The cost-control priority relies on the ERP and supply contracting; vendors that cut purchased-services or specialist costs (anesthesia, radiology) fit the $100 million savings effort.
- **Clinician retention and productivity**: Physician recruitment and retention is a stated priority, and ambient listening already covers over 1 million encounters; clinical documentation and workforce tools can extend it.
- **Rural Health Transformation spending**: Year 1 awards are mainly for capex and software, giving software and equipment vendors a funded window through September 30, 2027.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Community Health Systems, Inc. Annual Report on Form 10-K for the fiscal year ended December 31, 2025](https://www.sec.gov/Archives/edgar/data/1108109/000119312526059509/cyh-20251231.htm)

Annual report · 2026-02-19

- Community Health Systems (CHS) describes itself as "one of the nation's largest healthcare companies": at December 31, 2025 its subsidiaries owned or leased 69 affiliated hospitals with more than 10,000 beds (10,458 licensed beds) and operated more than 1,000 sites of care in 36 distinct markets across 14 states; headquarters in Franklin, Tennessee.
- FY2025 net operating revenues were $12,485 million (vs $12,634 million in 2024, -1.2%), but same-store net operating revenues rose $541 million, or 4.6%, driven by higher reimbursement rates, supplemental reimbursement program revenue and payor mix.
- Adjusted EBITDA was $1,526 million (12.2% margin, flat vs 2024); net income attributable to CHS was $509 million vs a $(516) million loss in 2024, helped by divestiture gains, debt extinguishment gains and a ~$163 million tax benefit from the 2025 Reconciliation Law.
- Single reportable segment (hospital operations); revenue is concentrated in Indiana (16.8%), Alabama (15.8%), Texas (11.9%), Tennessee (8.3%) and Florida (8.2%). Payor mix: Managed Care and other third-party payors 47.8%, Medicare Managed Care 18.0%, Medicare 17.4%, Medicaid 16.0%, Self-pay 0.8%.
- Portfolio pruning continues: four hospitals divested and majority interests in three sold in 2025 (over $1.0 billion of net proceeds), the lab outreach business sold to Labcorp for ~$194 million, and early-2026 exits from Scranton/Wilkes-Barre (Pennsylvania) and Tennova Healthcare - Clarksville (~$623 million), plus a $450 million agreement to sell Crestwood Medical Center in Huntsville.
- Balance sheet remains the central constraint: ~$10.4 billion of fixed-rate debt, debt at 113% of total capitalization, interest expense of $870 million; 2025 refinancings pushed out 2027 maturities and the ABL had no borrowings and ~$786 million of capacity.
- Strategy: regional networks (41 hospitals in 12 networks), more outpatient access points (ASCs, urgent care, freestanding EDs, imaging), physician recruitment (~1,700 employed physicians), a consumer-centric experience and centralization on an ERP (finance, HR, supply chain); capex was $335 million in 2025.
- Key risks flagged: the expiry of enhanced ACA subsidies at the end of 2025, Medicaid cuts and work requirements under the 2025 Reconciliation Law (six of its 14 states did not expand Medicaid), self-pay growth, rising medical specialist fees, labor costs and high leverage.

### [Community Health Systems, Inc. Quarterly Report on Form 10-Q for the quarter ended September 30, 2026](https://www.sec.gov/Archives/edgar/data/1108109/000119312526437869/cyh-20260930.htm)

Interim report · 2026-10-29

- Q3 2026 net operating revenues were $2.757 billion vs $3.087 billion a year earlier; same-store revenues rose $100 million (+3.8%), the drop coming from divested hospitals.
- Net loss attributable to CHS was $(86) million in Q3 2026 vs $130 million income in Q3 2025 (which included a ~$163 million tax benefit); nine-month loss of $(74) million vs $399 million income.
- The footprint has shrunk to 60 hospitals with more than 8,000 beds and more than 800 sites of care in 32 markets across 12 states, after 2026 divestitures in Arkansas (four hospitals), Pennsylvania (three), Alabama (one) and the 80% Clarksville interest in Tennessee: ~$1.6 billion of 2025 revenue sold for ~$1.2 billion of net proceeds.
- Payor mix is deteriorating: Self-pay 1.7% of Q3 revenue (0.8% a year earlier) and charity-care foregone revenue 21.2% of revenue (13.6%), which the company links to falling ACA marketplace coverage.
- Same-store volumes up (admissions +2.2%, adjusted admissions +3.6%) but revenue per adjusted admission only +0.2%; other operating expenses rose to 29.3% of revenue on medical specialist fees and supplemental program costs.
- Nine-month operating cash flow was $(55) million vs $277 million, driven by higher patient receivables; debt cut to ~$9.6 billion through a May tender (~$600 million of divestiture cash) and a February special call.
- CHS paid ~$54 million in 2026 for physician practices, clinics and controlling interests in two ASCs, and has accepted ~$27 million of Rural Health Transformation Program Year 1 awards.

### [Community Health Systems Q3 2026 earnings call transcript](https://www.tradingkey.com/news/transcripts/262253932-tradingkey)

Executive talk · Kevin Hammons, Chief Executive Officer · 2026-10-29

- CEO Kevin Hammons said Q3 2026 adjusted EBITDA was $280 million and results fell below the internal forecast because of "elevated uninsured volumes and temporary softness in commercial elective procedures".
- CFO Jason Johnson gave a 10.2% adjusted EBITDA margin vs 12.2%, an approximate 7% core decline, and same-store net revenue +3.8%; almost half the adjusted-admission growth came from uninsured patients.
- 2026 guidance cut again: net revenue $11.3-11.5 billion, adjusted EBITDA $1.225-1.275 billion (6.5% lower at the midpoint), operating cash flow $100-300 million; capex unchanged at $350-400 million.
- Management's read is that care is "deferred rather than lost": clinic visits +7.9% and orthopedic MRIs are up, but commercially insured patients with higher copays and deductibles are putting off orthopedic and general surgery.
- Cost actions already taken should save over $100 million a year; contract labor and supplies are under control, but medical specialist fees rose 13% (anesthesia, radiology).
- The ACA-exchange (HICS) disenrollment hit is now estimated at $80-90 million for 2026; net leverage rose to 7.2x despite $810 million of debt reduction year to date.
- Rural Health Transformation Year 1 awards of $25-30 million, from a roughly 30% application success rate; medium-term targets are being reassessed.
- Growth focus: outpatient entry points (ASCs, urgent care, freestanding EDs, physician practices), physician retention (physician turnover down over 40%) and ambient listening (over 1 million encounters).

### [Community Health Systems Q2 2026 earnings call transcript](https://www.webull.com/news/15277474514609153)

Executive talk · Kevin Hammons, Chief Executive Officer · 2026-07-23

- Q2 2026 adjusted EBITDA was $330 million vs $380 million (11.7% margin vs 12.1%), on a 9.8% fall in net revenue caused by smaller prior-period state-directed payment benefits and divestitures.
- Same-store net revenue +2.4% and adjusted admissions +2.9%, but about half the volume growth came from uninsured visits, so revenue per adjusted admission fell 0.5%.
- 2026 guidance lowered to net revenue of $11.4-11.6 billion and adjusted EBITDA of $1.3-1.375 billion, from an initial midpoint of $1.415 billion; the ACA-exchange (HIX) impact was raised to $50-75 million.
- Management blames consumer insecurity: gas prices after the Middle East hostilities, groceries and deductibles. Communities have a median household income of about $64,000 vs $81,000 nationally, and elective orthopedics and cardiac surgery are being deferred.
- Medical specialist fees rose about 19% to 5.6% of revenue, mainly anesthesia subsidies and radiology; labor (hourly rate +1.1%) and supplies (14.2% of revenue) are well controlled.
- Payers are auditing more claims before paying, slowing cash and growing AR, which CFO Jason Johnson calls a timing rather than a collection issue.
- Portfolio: four Arkansas hospitals sold for $110 million; majority stakes bought in Surgical Institute of Alabama and South Anchorage Surgery Center; ~$368 million of 2031 notes and $231 million of 2032 notes repurchased in May; leverage 6.7x.
- The 2027 Medicare outpatient rule (about 10.5% before the 340B payback, about 5% net) is described as possibly the best increase "ever".

## Questions about Community Health Systems

### What does Community Health Systems do?

It is a for-profit US hospital operator. At September 30, 2026 it owned or leased 60 affiliated hospitals and ran more than 800 sites of care in 32 markets across 12 states, mostly in non-urban areas.

### What is Community Health Systems' revenue?

FY2025 net operating revenues were $12,485 million with adjusted EBITDA of $1,526 million. After divestitures, 2026 guidance is net revenue of $11.3-11.5 billion.

### How many employees does Community Health Systems have?

Approximately 57,000 employees at the end of 2025, including approximately 1,700 employed physicians.

### Who leads Community Health Systems?

Kevin J. Hammons became CEO effective December 10, 2025, after serving as interim CEO from October 1, 2025. Jason Johnson is EVP and CFO.

### What is Community Health Systems' strategy?

Strengthen regional networks, add outpatient access points such as ASCs and urgent care, recruit physicians, centralize on an ERP, and sell hospitals outside core markets to reduce debt.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
